Severe Acute Respiratory Syndrome (SARS) Pneumonia

Explore clinical trials studying Severe Acute Respiratory Syndrome (SARS) Pneumonia. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Severe Acute Respiratory Syndrome (SARS) Pneumonia trial results

Completed

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

NCT04569877

Conditions: COVID-19, COVID-19 Pneumonia, Coronaviridae Infections, +12 more
Locations: Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany

Universitätsklinikum Essen Essen, Germany

Krankenhaus Nordwest GmbH Frankfurt am Main, Germany

Universitätsklinikum Frankfurt Frankfurt am Main, Germany

View Trial Details

Completed

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

NCT04681001

Conditions: COVID-19, Common Cold, Corona Virus Disease, +15 more
Locations: Gesundheitsverbund, Klinik Favoriten Vienna, Austria

Gesundheitsverbund Klinik Floridsdorf Vienna, Austria

View Trial Details

Completed

Practice Variation on Antithrombotics in COVID-19

NCT04998799

Conditions: COVID-19, COVID-19 Acute Respiratory Distress Syndrome, COVID-19 Pneumonia, +17 more
Locations: Reliance Hospital Mumbai, Mumbai, Mahrastra, India

View Trial Details

Completed

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2

NCT04323527

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations: Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz Manaus, Amazonas, Brazil

View Trial Details

Completed

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

NCT04342650

Conditions: COVID-19, Clinical Trial, Coronaviridae Infections, +13 more
Locations: Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz Manaus, Amazonas, Brazil

View Trial Details

Completed

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19

NCT04343729

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations: Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz Manaus, Amazonas, Brazil

View Trial Details

Completed

Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

NCT04323592

Conditions: ARDS, Human, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations: Marco Confalonieri Trieste, TS, Italy

View Trial Details

Severe Acute Respiratory Syndrome (SARS) Pneumonia

Severe Acute Respiratory Syndrome (SARS) Pneumonia trial results

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Practice Variation on Antithrombotics in COVID-19

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19

Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

Related conditions